title: A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.
authors.affiliation: *Maladies Infectieuses, Brussels, Belgium †Service de Maladies Infectieuses et Tropicales, Hospital Saint-Louis, AP-HP and University of Paris Sorbonne Cité, INSERM, Paris, France ‡Department of Infectious Diseases, Hennepin County Medical Center, Minneapolis, MN §Therapeutic Concepts, Houston, TX ‖Department of Medicine I, University of Bonn, Bonn, Germany ¶Orlando Immunology Center, Orlando, FL #Gilead Sciences, Foster City, CA.
authors.forename: Nathan
authors.initials: N
authors.lastname: Clumeck
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Molina
authors.forename: Keith
authors.initials: K
authors.lastname: Henry
authors.forename: Joseph
authors.initials: J
authors.lastname: Gathe
authors.forename: Jürgen K
authors.initials: JK
authors.lastname: Rockstroh
authors.forename: Edwin
authors.initials: E
authors.lastname: DeJesus
authors.forename: Xuelian
authors.initials: X
authors.lastname: Wei
authors.forename: Kirsten
authors.initials: K
authors.lastname: White
authors.forename: Marshall W
authors.initials: MW
authors.lastname: Fordyce
authors.forename: Martin S
authors.initials: MS
authors.lastname: Rhee
authors.forename: Javier
authors.initials: J
authors.lastname: Szwarcberg
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D004338:Drug Combinations; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D013607:Tablets / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D004338:Drug Combinations; D013607:Tablets